Werewolf Therapeutics Statistics
Total Valuation
HOWL has a market cap or net worth of $15.70 million. The enterprise value is $6.90 million.
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HOWL has 48.60 million shares outstanding. The number of shares has increased by 6.40% in one year.
| Current Share Class | 48.60M |
| Shares Outstanding | 48.60M |
| Shares Change (YoY) | +6.40% |
| Shares Change (QoQ) | -1.26% |
| Owned by Insiders (%) | 1.40% |
| Owned by Institutions (%) | 18.14% |
| Float | 45.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.29 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 3.09.
| Current Ratio | 1.27 |
| Quick Ratio | 1.21 |
| Debt / Equity | 3.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.60 |
Financial Efficiency
Return on equity (ROE) is -161.89% and return on invested capital (ROIC) is -44.78%.
| Return on Equity (ROE) | -161.89% |
| Return on Assets (ROA) | -39.07% |
| Return on Invested Capital (ROIC) | -44.78% |
| Return on Capital Employed (ROCE) | -264.84% |
| Weighted Average Cost of Capital (WACC) | 9.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.02M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.97% in the last 52 weeks. The beta is 0.27, so HOWL's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -72.97% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.91 |
| Relative Strength Index (RSI) | 31.05 |
| Average Volume (20 Days) | 665,526 |
Short Selling Information
The latest short interest is 964,624, so 1.98% of the outstanding shares have been sold short.
| Short Interest | 964,624 |
| Short Previous Month | 949,598 |
| Short % of Shares Out | 1.98% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 1.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | -33.91M |
| Operating Income | -51.65M |
| Pretax Income | -56.27M |
| Net Income | -56.27M |
| EBITDA | -50.05M |
| EBIT | -51.65M |
| Earnings Per Share (EPS) | -$1.23 |
Full Income StatementBalance Sheet
The company has $46.45 million in cash and $37.65 million in debt, giving a net cash position of $8.80 million or $0.18 per share.
| Cash & Cash Equivalents | 46.45M |
| Total Debt | 37.65M |
| Net Cash | 8.80M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 12.20M |
| Book Value Per Share | 0.25 |
| Working Capital | 10.22M |
Full Balance SheetCash Flow
| Operating Cash Flow | -51.94M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.61M |
| Net Borrowing | n/a |
| Free Cash Flow | -51.94M |
| FCF Per Share | -$1.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |